Search Results - "Rudolf Rucman"
-
1
Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities
Published in Applied microbiology and biotechnology (01-12-2018)“…Lactic acid bacteria (LAB) are attractive hosts for the expression of heterologous proteins and can be engineered to deliver therapeutic proteins or peptides…”
Get full text
Journal Article -
2
Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?
Published in Current pharmaceutical design (01-01-2017)“…Selye's syndrome produced by diverse nocuous agents and "response to damage as such" means Selye's stress triad in stress coping response to reestablish…”
Get more information
Journal Article -
3
Stable gastric pentadecapeptide BPC 157-NO-system relation
Published in Current pharmaceutical design (01-02-2014)“…We reviewed stable gastric pentadecapeptide BPC 157-NO-system-relation, its close participation in Moncada's (maintained vascular integrity, platelets control)…”
Get more information
Journal Article -
4
Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future
Published in Gut and liver (01-03-2020)“…We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a likely mediator of Robert's stomach cytoprotection/adaptive…”
Get full text
Journal Article -
5
Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
Published in Current pharmaceutical design (01-01-2013)“…Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, proven in clinical trials to be both safe in inflammatory bowel disease (PL-10,…”
Get more information
Journal Article -
6
BPC 157 and blood vessels
Published in Current pharmaceutical design (01-02-2014)“…This review focuses on the described effects of BPC 157 on blood vessels after different types of damage, and elucidate by investigating different aspects of…”
Get more information
Journal Article -
7
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
Published in Current pharmaceutical design (01-06-2011)“…Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, safe in inflammatory bowel disease clinical trials (GEPPPGKPADDAGLV, M.W. 1419, PL…”
Get more information
Journal Article -
8
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Published in Current neuropharmacology (01-01-2016)“…Background: Brain-gut interaction involves, among others, peptidergic growth factors which are native in GI tract and have strong antiulcer potency and thus…”
Get full text
Journal Article -
9
Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future
Published in Gut and liver (30-03-2020)“…We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a likely mediator of Robert’s stomach cytoprotection/adaptive…”
Get full text
Journal Article -
10
Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future
Published in Gut and liver (30-03-2020)“…We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a likely mediator of Robert’s stomach cytoprotection/adaptive…”
Get full text
Journal Article -
11
Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future
Published in Gut and liver (30-03-2020)“…We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a likely mediator of Robert’s stomach cytoprotection/adaptive…”
Get full text
Journal Article -
12
Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye’s Stress Coping Response: Progress, Achievements, and the Future
Published in Gut and liver (30-03-2020)“…We reviewed again the significance of the stable gastric pentadecapeptide BPC 157 as a likely mediator of Robert’s stomach cytoprotection/adaptive…”
Get full text
Journal Article -
13
The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation
Published in Journal of physiology, Paris (01-12-1999)“…A clear protection of the gastrointestinal tract and an evident anti-inflammatory effect were shown for a novel stomach pentadecapeptide BPC 157 (i.p./i.g.) in…”
Get full text
Journal Article -
14
Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats
Published in Journal of physiology, Paris (2001)“…Unlike severe gastric damage acutely induced by ethanol administration in rat, the ulcerogenic effect of chronic alcohol administration (3.03 g/kg b.w. or 7.28…”
Get full text
Journal Article -
15
Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisolone
Published in Journal of physiology, Paris (2001)“…Recently, we showed cysteamine-duodenal lesions without gastric acid, since they were induced also in gastrectomized rats, as in naive rats, and they were…”
Get full text
Journal Article -
16
Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat
Published in Journal of physiology, Paris (2001)“…After demonstration that cysteamine induced duodenal lesions in gastrectomized rats, while a number of antiulcer drugs mitigated these lesions, it was shown…”
Get full text
Journal Article -
17
Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats
Published in Journal of physiology, Paris (01-12-1999)“…Recently, the effectiveness of pentadecapeptide BPC 157 and other anti-ulcer agents, called `direct cytoprotection', was evidenced in totally gastrectomized…”
Get full text
Journal Article -
18
Stable anti‐ulcer gastric pentadecapeptide BPC 157 also for multiple sclerosis: Counteraction of cuprizone brain injuries and motor disability
Published in The FASEB journal (01-04-2013)“…Abstract only Like other agents for ulcerative colitis (i.e., natalizumab), stable gastric pentadecapeptide BPC 157 may affect multiple sclerosis (MS). BPC 157…”
Get full text
Journal Article -
19
Stable gastric pentadecapeptide BPC 157 for colitis and multiple sclerosis: Healing of cysteamine‐colitis and colon‐colon‐ anastomosis
Published in The FASEB journal (01-04-2013)“…Abstract only BPC 157 is interesting as an original anti‐ulcer peptide (GEPPPGKPADDAGLV,M.W. 1419) stable in human gastric juice more than 24 hours, successful…”
Get full text
Journal Article -
20
Pentadecapeptide BPC 157 after 70% liver resection in rats
Published in The FASEB journal (01-04-2013)“…Abstract only We suggest that stable gastric pentadecapeptide BPC 157 improves function and liver regeneration after 70% liver resection in rats since it can…”
Get full text
Journal Article